Home
Sign up
Sign in
Home
Sign up
Sign in
www.camwebdir.co.uk
CamWebDir
/
Employers
Amphista Therapeutics
Website
amphista.com
Platform
WordPress
Website built by
gig.health
·
gig.health
Address
CB21 6GQ
Last crawled
30 Jun 2026 · 5 pages
Recent news
6
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
8 Jun 2026
Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program
24 Apr 2026
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
21 Apr 2026
Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs
23 Mar 2026
Amphista Therapeutics appoints Louise Modis Ph.D. as CEO and Patrick Kelly M.D. as CMO and provides a business update as the Company prepares to file IND application for AMX-883
18 Mar 2026
Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic
26 Feb 2026